Status of interleukin-6 and hepcidin levels in first-time haemodialysis patients
Background The risk of chronic kidney disease stage 5 and its progression depend on the stage and the underlying diagnosis. Haemodialysis has become the long-term maintenance therapy for these patients. The interaction among interleukin-6 (IL-6), hepcidin and the iron exporter ferroportin is a majo...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2017-01-01
|
| Series: | The Egyptian Journal of Internal Medicine |
| Subjects: | |
| Online Access: | http://www.esim.eg.net/article.asp?issn=1110-7782;year=2017;volume=29;issue=2;spage=54;epage=58;aulast=Hutagaol |
| _version_ | 1818347675995602944 |
|---|---|
| author | Sari Hutagaol Harun R Lubis Lukman H Zein Adikoesoema Aman Stephen C.L. Koh Herman Hariman |
| author_facet | Sari Hutagaol Harun R Lubis Lukman H Zein Adikoesoema Aman Stephen C.L. Koh Herman Hariman |
| author_sort | Sari Hutagaol |
| collection | DOAJ |
| description | Background
The risk of chronic kidney disease stage 5 and its progression depend on the stage and the underlying diagnosis. Haemodialysis has become the long-term maintenance therapy for these patients. The interaction among interleukin-6 (IL-6), hepcidin and the iron exporter ferroportin is a major contributor to the iron-deficiency anaemia of chronic disease. The aim of the present study was to investigate the effects of polysulphone dialyzer membrane on serum IL-6 and hepcidin, including haemoglobin levels, in first-time patients undergoing five cycles of haemodialysis.
Patients and methods
Totally, 11 patients (male: five, female: six) were recruited for the present study after obtaining written informed consent. Their mean age was 57.4±13.4 years, and they were undergoing haemodialysis for the first time. Hepcidin, IL-6 and haemoglobin levels were determined before the first cycle and the fifth cycle and after the fifth cycle of haemodialysis. Pearson’s correlation coefficients were also determined.
Results and discussion
No statistically significant differences were observed before the first cycle and after the fifth cycle of haemodialysis in haemoglobin, IL-6 and hepcidin levels nor between pre-fifth and post-fifth cycle values, except for IL-6, which showed a significant mean reduction (P=0.04) from the pre-fifth cycle of 67.0 pg/ml to a mean value of 42.9 pg/ml (64.0% reduction). Analysis of variance showed no significant variation in the parameters studied, and no significant correlations between haemoglobin and IL-6, haemoglobin and hepcidin, and IL-6 and hepcidin were found.
Conclusion
In this short study of five-cycle haemodialysis, significant reduction in IL-6 with no significant change in hepcidin levels was found, even though severe anaemia was present. Kidney dysfunction probably results in decreased clearance of inflammatory markers and may not be improved by haemodialysis alone. Moreover, a different approach to reduce these markers is therefore warranted. |
| first_indexed | 2024-12-13T17:37:56Z |
| format | Article |
| id | doaj.art-9475b03bf4c14fdf81a243b5b56038ae |
| institution | Directory Open Access Journal |
| issn | 1110-7782 2090-9098 |
| language | English |
| last_indexed | 2024-12-13T17:37:56Z |
| publishDate | 2017-01-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | The Egyptian Journal of Internal Medicine |
| spelling | doaj.art-9475b03bf4c14fdf81a243b5b56038ae2022-12-21T23:36:51ZengSpringerOpenThe Egyptian Journal of Internal Medicine1110-77822090-90982017-01-01292545810.4103/ejim.ejim_27_16Status of interleukin-6 and hepcidin levels in first-time haemodialysis patientsSari HutagaolHarun R LubisLukman H ZeinAdikoesoema AmanStephen C.L. KohHerman HarimanBackground The risk of chronic kidney disease stage 5 and its progression depend on the stage and the underlying diagnosis. Haemodialysis has become the long-term maintenance therapy for these patients. The interaction among interleukin-6 (IL-6), hepcidin and the iron exporter ferroportin is a major contributor to the iron-deficiency anaemia of chronic disease. The aim of the present study was to investigate the effects of polysulphone dialyzer membrane on serum IL-6 and hepcidin, including haemoglobin levels, in first-time patients undergoing five cycles of haemodialysis. Patients and methods Totally, 11 patients (male: five, female: six) were recruited for the present study after obtaining written informed consent. Their mean age was 57.4±13.4 years, and they were undergoing haemodialysis for the first time. Hepcidin, IL-6 and haemoglobin levels were determined before the first cycle and the fifth cycle and after the fifth cycle of haemodialysis. Pearson’s correlation coefficients were also determined. Results and discussion No statistically significant differences were observed before the first cycle and after the fifth cycle of haemodialysis in haemoglobin, IL-6 and hepcidin levels nor between pre-fifth and post-fifth cycle values, except for IL-6, which showed a significant mean reduction (P=0.04) from the pre-fifth cycle of 67.0 pg/ml to a mean value of 42.9 pg/ml (64.0% reduction). Analysis of variance showed no significant variation in the parameters studied, and no significant correlations between haemoglobin and IL-6, haemoglobin and hepcidin, and IL-6 and hepcidin were found. Conclusion In this short study of five-cycle haemodialysis, significant reduction in IL-6 with no significant change in hepcidin levels was found, even though severe anaemia was present. Kidney dysfunction probably results in decreased clearance of inflammatory markers and may not be improved by haemodialysis alone. Moreover, a different approach to reduce these markers is therefore warranted.http://www.esim.eg.net/article.asp?issn=1110-7782;year=2017;volume=29;issue=2;spage=54;epage=58;aulast=Hutagaolhaemodialysishaemoglobinhepcidininterleukin-6 |
| spellingShingle | Sari Hutagaol Harun R Lubis Lukman H Zein Adikoesoema Aman Stephen C.L. Koh Herman Hariman Status of interleukin-6 and hepcidin levels in first-time haemodialysis patients The Egyptian Journal of Internal Medicine haemodialysis haemoglobin hepcidin interleukin-6 |
| title | Status of interleukin-6 and hepcidin levels in first-time haemodialysis patients |
| title_full | Status of interleukin-6 and hepcidin levels in first-time haemodialysis patients |
| title_fullStr | Status of interleukin-6 and hepcidin levels in first-time haemodialysis patients |
| title_full_unstemmed | Status of interleukin-6 and hepcidin levels in first-time haemodialysis patients |
| title_short | Status of interleukin-6 and hepcidin levels in first-time haemodialysis patients |
| title_sort | status of interleukin 6 and hepcidin levels in first time haemodialysis patients |
| topic | haemodialysis haemoglobin hepcidin interleukin-6 |
| url | http://www.esim.eg.net/article.asp?issn=1110-7782;year=2017;volume=29;issue=2;spage=54;epage=58;aulast=Hutagaol |
| work_keys_str_mv | AT sarihutagaol statusofinterleukin6andhepcidinlevelsinfirsttimehaemodialysispatients AT harunrlubis statusofinterleukin6andhepcidinlevelsinfirsttimehaemodialysispatients AT lukmanhzein statusofinterleukin6andhepcidinlevelsinfirsttimehaemodialysispatients AT adikoesoemaaman statusofinterleukin6andhepcidinlevelsinfirsttimehaemodialysispatients AT stephenclkoh statusofinterleukin6andhepcidinlevelsinfirsttimehaemodialysispatients AT hermanhariman statusofinterleukin6andhepcidinlevelsinfirsttimehaemodialysispatients |